This inventor holds 1 USPTO granted patent. Top assignee: Kirin Beer Kabushiki Kaisha. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Naoki Matsunaga: Innovator in Pharmaceutical Chemistry
Introduction
Naoki Matsunaga is a notable inventor based in Gunma-ken, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for therapeutic applications. His work is characterized by a focus on creating effective treatments for various diseases.
Latest Patents
Matsunaga holds a patent for a compound titled N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea salt in crystalline form. This invention provides a crystal of a pharmaceutically acceptable salt that is useful in the therapy of diseases such as tumors, diabetic retinopathy, chronic rheumatism, psoriasis, atherosclerosis, Kaposi's sarcoma, and exudation type age-related maculopathy. The characteristics of this crystal make it suitable for applications in oral pharmaceutical preparations.
Career Highlights
Matsunaga is currently associated with Kirin Beer Kabushiki Kaisha, where he continues to engage in research and development. His work has led to advancements in the pharmaceutical industry, particularly in the creation of new therapeutic agents.
Collaborations
Matsunaga has collaborated with notable colleagues such as Satoshi Yoshida and Ayako Yoshino. These partnerships have contributed to the success of his research and the development of innovative solutions in the pharmaceutical field.
Conclusion
Naoki Matsunaga's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His patent and ongoing work continue to pave the way for new treatments that address significant health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
